Evidence map›Paper›PMID 31269743›Full record

ArticleInternational journal of molecular sciences2019

A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum.

Sophie Gravel, Benoit Panzini, Francois Belanger, Jacques Turgeon, Veronique Michaud

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sophie GravelFaculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada.ORCID 0000-0002-1946-3414
Benoit PanziniCHUM-Centre Hospitalier de l'Université de Montréal, Department of Gastroenterology, Montreal, QC H2X 0A9, Canada.
Francois BelangerFaculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Jacques TurgeonFaculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Veronique MichaudFaculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada. vmichaud@trhc.com.ORCID 0000-0002-1399-6447
Centre Hospitalier de l’Université de Montréal · CAUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research 299309
6 · The paper itself

Abstract

To characterize effects of type 2 diabetes (T2D) on mRNA expression levels for 10 Cytochromes P450 (CYP450s), two carboxylesterases, and three drug transporters (ABCB1, ABCG2, SLCO2B1) in human duodenal biopsies. To compare drug metabolizing enzyme activities of four CYP450 isoenzymes in duodenal biopsies from patients with or without T2D. mRNA levels were quantified (RT-qPCR) in human duodenal biopsies obtained from patients with (

Indexed as

AdultAgedATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2Carboxylic Ester HydrolasesCytochrome P-450 Enzyme SystemDiabetes Mellitus, Type 2DuodenumFemaleGene Expression RegulationHumansMaleMiddle AgedNeoplasm ProteinsOrganic Anion TransportersABCB1 protein, humanABCG2 protein, humanATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2Carboxylic Ester HydrolasesCytochrome P-450 Enzyme SystemNeoplasm ProteinsOrganic Anion TransportersRNA, MessengerSLCO2B1 protein, humancytochromes P450drug metabolismintestinetype II diabetes mellitus

Identifiers

PMID31269743
PMCPMC6651059
OpenAlexW2955351256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.